• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22263 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium for moderate-to-severe chronic obstructive pulmonary disease: a review of the clinical effectiveness and cost-effectiveness
2001     NIHR Horizon Scanning Centre (NIHR HSC) Tiotropium for COPD - horizon scanning review
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium compared with ipratropium for patients with moderate to severe chronic obstructive pulmonary disease: a review of the clinical effectiveness
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Tiotropium bromide
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinzaparin versus dalteparin or enoxaparin for the treatment of venous thromboembolism in adults: safety and guidelines
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tinzaparin sodium (Innohep®)
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Tinnitus retraining therapy: a review of the clinical effectiveness
1998     Wessex Institute for Health Research and Development (WIHRD) Tinnitus retraining therapy
2004     Washington State Department of Labor and Industries (WSDLI) Tinnitus retraining therapy
2004     WorkSafeBC Tinnitus retraining therapy
2022     WorkSafeBC Tinnitus and the COVID-19 vaccine
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Tin-117m DTPA
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Timothy grass standardized allergenic extract (Grastek — Merck Canada Inc.) indication: allergic rhinitis (grass pollen)
2019     Penn Medicine Center for Evidence-based Practice (CEP) Timing of valve replacement for patients with infective endocarditis and intracranial embolism
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Timing of umbilical cord clamping for neonatal and maternal outcomes
2017     NIHR Health Technology Assessment programme Timing of surgical intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip 'Op)
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of enoxaparin administration for the prophylaxis of venous thromboembolism: clinical evidence and guidelines
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Timing of antibiotic therapy for neisseria gonorrhoeae infection
2008     NIHR Health Technology Assessment programme Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review
2008     NIHR Health Technology Assessment programme Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review
2001     Centre for Clinical Effectiveness (CCE) Time to commencement of oral feeding following laryngectomy
2015     NIHR Horizon Scanning Centre (NIHR HSC) Tildrakizumab for moderate to severe plaque psoriasis
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Tigecycline: usefulness of its clinical application
2011     National Institute for Health and Care Excellence (NICE) Ticagrelor for the treatment of acute coronary syndromes. NICE technology appraisal guidance 236
2011     NIHR Health Technology Assessment programme Ticagrelor for the treatment of acute coronary syndromes
2019     Agency for Care Effectiveness (ACE) Ticagrelor for preventing thrombotic events in adults with acute coronary syndromes
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for secondary prevention of cardiovascular disease events in patients with prior myocardial infarction
2015     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (Brilique) for preventing thombotic events in patients with acute ischaemic stroke or high risk transient ischaemic attack
2008     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (AZD6140) for acute coronary syndrome
1992     Health Services Utilization and Research Commission (HSURC) Thyroid testing
2012     HAYES, Inc. Thyroid hormone receptor beta (THRB) gene testing in resistance to thyroid hormone (RTH)
2022     Swiss Federal Office of Public Health (FOPH) Thyroid function tests for the diagnosis of suspected primary or secondary thyroid dysfunction
2008     HAYES, Inc. Thymus transplantation for treatment of children with DiGeorge syndrome
2014     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for epidermolysis bullosa
2012     NIHR Horizon Scanning Centre (NIHR HSC) Thymosin beta-4 for dry eye syndrome
2000     University HealthSystem Consortium (UHC) Thymosin alpha-1
2005     NIHR Horizon Scanning Centre (NIHR HSC) Thymalfasin (Zadaxin) for hepatitis C virus - horizon scanning review
2017     HAYES, Inc. ThyGenX and ThyraMIR (Interpace Diagnostics)
2008     HAYES, Inc. Thrombosis panel for risk assessment for venous thromboembolism (VTE) or obstetric complications
2024     NIHR Health Technology Assessment programme Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research
2011     Norwegian Knowledge Centre for the Health Services (NOKC) Thromboprophylactic treatment with rivaroxaban or dabigatran compared with enoxaparin or dalteparin in patients undergoing elective hip- or knee replacement surgery
2009     NIHR Health Technology Assessment programme Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Thrombophilia testing for women who have had pregnancy loss: clinical evidence, cost-effectiveness, and guidelines
2000     University HealthSystem Consortium (UHC) Thrombolytics for MI
1992     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Thrombolytic therapy: current status - summary
2015     NIHR Health Technology Assessment programme Thrombolytic therapy for pulmonary embolism
1995     University HealthSystem Consortium (UHC) Thrombolytic therapy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Thrombolytic drugs for cardiac arrest: a review of the clinical effectiveness
2003     The Swedish Council on Health Technology Assessment (SBU) Thrombolysis with plasminogen activator (rtPA) in stroke - early assessment briefs (Alert)
1997     Scottish Health Purchasing Information Centre (SHPIC) Thrombolysis for heart attacks[TEST COPY]
1997     Scottish Health Purchasing Information Centre (SHPIC) Thrombolysis for heart attacks
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
2011     NIHR Horizon Scanning Centre (NIHR HSC) ThromboLUX™ for determining platelet quality
1999     Norwegian Knowledge Centre for the Health Services (NOKC) Thrombolitic medication for treatment of stroke
2013     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography-guided heparin use for the prevention of venous thromboembolism
2011     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography for determining transfusion requirements
2014     Penn Medicine Center for Evidence-based Practice (CEP) Thromboelastography
2005     Danish Institute for Health Services Research (DSI) Thrombo-Base. A technology assessment of a decision support system and a clinical database for anticoagulant treatment
2004     National Institute for Clinical Excellence (NICE) Thrombin injections for pseudoaneurysms
2008     Belgian Health Care Knowledge Centre (KCE) Threshold values for cost-effectiveness in health care
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Three-wheel and four-wheel scooters: alternatives to powered wheelchairs?
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Three-dimensional electroanatomical mapping in arrhythmia ablation
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for high-risk pregnancies and routine screening
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal limbs and skeletal structures
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal growth and volume measurements
2006     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for fetal cardiovascular diagnosis
2006     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for extrafetal and maternal structures in pregnancy
2005     HAYES, Inc. Three-dimensional and four-dimensional ultrasound for diagnosis of fetal head abnormalities
2019     NIHR Health Technology Assessment programme Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation
1996     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Thoravision - systematic review, expert panel
2003     Adelaide Health Technology Assessment (AHTA) Thoratec heartmate (R) left ventricular assist device for patients with heart failure who are ineligible for heart transplantation
2020     NIHR Health Technology Assessment programme Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
2006     National Institute for Health and Care Excellence (NICE) Thoracoscopically assisted oesophagectomy
2011     National Institute for Health and Care Excellence (NICE) Thoracoscopic repair of congenital diaphragmatic hernia in neonates
2004     ECRI Thoracic sympathectomy for treatment of intractable Raynaud's Syndrome
2002     Agency for Healthcare Research and Quality (AHRQ) Thoracic electrical bioimpedance
2011     HAYES, Inc. Thoracic aortic aneurysms and dissections (TAAD)
2023     Agency for Care Effectiveness (ACE) Thoracic and abdominal endovascular repair (T/EVAR) for the structural support of aortic aneurysm
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Thoracic and abdominal endovascular repair
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Third-line therapy for patients with type 2 diabetes inadequately controlled with metformin and a sulfonylurea
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Third-line pharmacotherapy for type 2 diabetes erratum
2008     Adelaide Health Technology Assessment (AHTA) Third Eye retroscope(TM) for the retrogade viewing of the colon
2012     HAYES, Inc. Third eye retroscope (Avantis Medical Systems Inc.) for aiding the colonoscopic detection of colorectal polyps and adenomas
2015     Health Council of the Netherlands Gezondheidsraad (GR) Thiotepa - health-based calculated occupational cancer risk values
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A systematic review and quality appraisal
2015     Technology Assessment at SickKids (TASK) Thiopurine S-methyltransferase testing for averting drug toxicity in patients receiving thiopurines: A meta-analysis of diagnostic test accuracy
2009     HAYES, Inc. Thiopurine S-Methyltransferase (TPMT) genotyping and phenotyping for predicting response to thiopurine drug therapy for Inflammatory Bowel Disease
2013     Technology Assessment at SickKids (TASK) Thiopurine dosing using thiopurine methyltransferase status: a systematic review of clinical guidance
2023     NIHR Health Services and Delivery Research programme Thinking ahead about medical treatments in advanced illness: a qualitative study of barriers and enablers in end-of-life care planning with patients and families from ethnically diverse backgrounds
2003     HAYES, Inc. Thin-layer pap preparations for detecting cervical cancer
2007     Canadian Agency for Drugs and Technologies in Health (CADTH) Thiazide diuretics as first-line treatment for hypertension: meta-analysis and economic evaluation
2005     Adelaide Health Technology Assessment (AHTA) TherOx AO System: hyperoxemic perfusion for the treatment of microvascular ischaemia in patients with acute myocardial infarction
2005     Adelaide Health Technology Assessment (AHTA) TherOx (R) AO system: hyperoxemic perfusion for myocardial infarction
1998     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Thermotherapy of benign prostate hypertrophy - primary research
2008     VA Technology Assessment Program (VATAP) Thermosurgery in dermatology
2011     Penn Medicine Center for Evidence-based Practice (CEP) Thermometers for pediatric use
1999     Conseil d'Evaluation des Technologies de la Santé du Quebec (CETS) Thermography - nonsystematic review
2023     Finnish Coordinating Center for Health Technology Assessment (FinCCHTA) Thermidas thermal imaging system